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Abstract 
Mitochondrial function relies on the function of oxidative phosphorylation to synthesise ATP and 
generate an electrochemical gradient across the inner mitochondrial membrane. These coupled 
processes are mediated by five multi-subunit complexes that reside in this inner membrane. These 
complexes are the product of both nuclear and mitochondrial gene products. Defects in the function 
or assembly of these complexes can lead to mitochondrial diseases due to deficits in energy 
production and mitochondrial functions. Appropriate biogenesis and function are mediated by a 
complex number of assembly factors that promote maturation of specific complex subunits to form 
the active oxidative phosphorylation complex. The understanding of the biogenesis of each complex 
has been informed by studies in both simple eukaryotes such as Saccharomyces cerevisiae and 
human patients with mitochondrial diseases. These studies reveal each complex assembles through 
a pathway using specific subunits and assembly factors to form kinetically distinct but related 
assembly modules. The current understanding of these complexes has embraced the revolutions in 
genomics and proteomics to further our knowledge on the impact of mitochondrial biology in 
genetics, medicine, and evolution. 
 
Introduction 
Mitochondrial electron transport chain complexes exist in the inner mitochondrial 
membrane (IMM) and are composed of multiple subunits that either span the IMM or associate with 
the IMM exposed to either the matrix or inter-membrane space (IMS).  The structure of these 
complexes is further complicated by associations between complexes, referred to as 
supercomplexes.  The architecture of these supercomplexes is proposed to mediate efficient 
electron transfer from reducing equivalents generated during oxidative metabolism such as NADH 
and FADH2 via electron transport complexes and mobile electron carriers ultimately reducing 
molecular oxygen to water.   
Each electron transport complex harbours co-factors that enable electron transfer in a 
specific and rapid manner.  These include flavin mononucleotide (FMN), iron-sulphur (Fe-S) clusters, 
haem/cytochromes, and metal ions such as copper.  Electrons are passed from co-factors with 
higher redox states to those with lower redox states terminating in the reduction of molecular 
oxygen.  The location of each co-factor is determined by the association with the specific subunit 
where it is bound.  This allows a predictable transfer of electrons from entry points in complex I 
(NADH:ubiquinone oxidoreductase) and complex II (succinate dehydrogenase – SDH) that converge 
at the mobile electron carrier co-enzyme Q (ubiquinone/ubiquinol) prior to transfer to complex III 
(co-enzyme Q:cytochrome c oxidoreductase or bc1 complex).  The association of each co-factor is 
mediated at a specific stage in the biogenesis of the complex by a specific assembly factor. This 
ensures the potentially redox active co-factor has minimal time as a free and potentially highly 
reactive molecular entity.    
Most eukaryotic electron transport complexes are the product of two genomes.  The 
majority of mitochondrial proteins are encoded by the nuclear genome and undergo cytosolic 
translation and incorporation into the mitochondria through outer mitochondrial membrane (OMM) 
and IMM specific protein translocation complexes (Calvo et al., 2016).  A small, but essential, 
number of electron transport complex genes are encoded by the mitochondrial genome.  These 
undergo mitochondrial transcription and translation and are incorporated into the IMM via specific 
translocation complexes (Ott and Herrmann, 2010). Once in the IMM these proteins associate with 
cognate assembly factors and structural subunits in a series of kinetically related assembly 
complexes.   
Owing to their complexity, the assembly of each of these electron transport complexes 
needs to be a tightly regulated and efficient process that minimises generation of non-functional 
assembly intermediates and/or toxic by products such as reactive oxygen species (ROS).  Biogenesis 
is also controlled by availability of required gene products and co-factors. An imbalance in electron 
transport complexes can lead to a decrease in ATP production and also a back flow of electrons that 
could result in excessive generation of ROS.  These are thought to be the causes of a number of 
pathologies associated with impaired electron transport chain biogenesis.   
Characterisation of the assembly of electron transport chain complexes originally stemmed 
from the genetic investigations of budding yeast, Saccharomyces cerevisiae, due to the inability of 
respiratory incompetent cells to grow on substrates such as ethanol, glycerol and lactate. This 
allowed for rapid identification of many genes whose absence impaired electron transport chain 
biogenesis (Tzagoloff and Dieckmann, 1990).  The elucidation of the function of each of the genes 
has identified functions related to mitochondrial translation, messenger RNA stability, tRNA, 
structural subunits of the electron transport chain complexes and multiple assembly factors for each 
electron transport complex.  The functions of these assembly factors are wide-ranging and are 
responsible for translation control, co-factor incorporation and potentially chaperone-like activity.   
In this review article, we will discuss the assembly complexes associated with each electron 
transport chain complex highlighting the composition of the complexes and their modular nature as 
well as unanswered questions related to each of these electron transport chain complex assembly 
pathways.   
 
Complex I – NADH:ubiquinone oxidoreductase 
1 - Structure and function 
Complex I (NADH:ubiquinone oxidoreductase) is an IMM complex comprised of 45 subunits, 
derived from both the nuclear and mitochondrial genomes in humans (Figure 1).  Fourteen central 
subunits are structurally conserved from bacteria to mammals and seven of these subunits are 
encoded by the mitochondrial genome and synthesised using the mitochondrial transcription and 
translation machinery, while the remaining subunits are encoded in the nucleus and synthesised in 
the cytosol and require import into the IMM. In consequence of such large multimeric structure, 
isolated complex I deficiency is the major cause of mitochondrial disease in infancy and childhood 
with a wide range of clinical phenotypes such as Leigh syndrome, mitochondrial 
encephalomyopathy, lactic acidosis with stroke-like episodes (MELAS), neonatal cardiomyopathy and 
hepatopathy with tubulopathy (Rodenburg, 2016). Mitochondrial encoded complex I subunits are 
found in most eukaryotes and therefore assembly can be determined using in fungal models such as 
Yarrowia lipolytica and Neurospora crassa. Of the 45 different proteins of mammalian complex I, 
eight have no orthologue in Y. lipolytica, while five of the 42 subunits of Y. lipolytica enzyme are not 
found in mammals (Wirth et al., 2016).  However, in Saccharomyces cerevisiae complex I exists as 
one of three single polypeptide NADH dehydrogenase enzymes, Ndi1p, Nde1p and Nde2p, that 
accept electrons from extra-mitochondrial or intra-mitochondrial sources and pass onto ubiquinone, 
much like higher eukaryotic complex I.  As these are single subunit enzymes and do not possess 
proton translocation activity, S. cerevisiae can not be used as a model for Complex I assembly or 
function.  
The assembled multi-subunit complex I is a proton pump, translocating protons from the matrix 
to the IMM to participate in the generation of the mitochondrial membrane potential, in fact 
complex I is the major contributor of the proton motive force that drives aerobic ATP synthesis.  An 
electron transfer complex (the N module) harvests electrons from NADH on the matrix side through 
Flavin Mononucleotide (FMN) reduction and passes them on to a series of eight canonical iron-
sulphur clusters to ubiquinone, an IMM lipid soluble electron carrier, at the Q module. Complex I 
also contain a P module that is responsible for proton translocation that is coupled to electron 
transfer. With a molecular mass of about 1 MDa, complex I is the largest component of the 
respiratory chain, with many subunits, that need to be assembled appropriately to maintain cellular 
vitality. In many organisms, Complex I presents as an L-shaped architecture with a membrane arm 
and a peripheral arm.  The initial redox reactions occur in the N module peripheral arm that is 
exposed to the matrix containing the flavoprotein and the eight iron-sulphur clusters that ultimately 
transfer the electrons. Electron leakage in these transfer paths account for significant formation of 
mitochondrial ROS, which has a direct impact in cell physiology (Barrientos and Moraes, 1998). 
Rotenone inhibits complex I activity by blocking ubiquinone that can promote apoptotic cell death 
by increasing complex I ROS release (Chance et al., 1963; Li et al., 2003). In many organisms, 
Complex I presents a regulatory transition in active (A-form) and deactivated (D-form) forms (Kotlyar 
and Vinogradov, 1990).  The reversible switch between A-form and D-form is important, for instance, 
to minimize electron leakage, as well it was shown to prevent cardiac ischemia/reperfusion damage 
(Chouchani et al., 2013).  The complexity of Complex I  enzyme has made the study of assembly 
more technically challenging, because of the size of the complex and the number of subunits, but 
recent publications using high content proteomics and cryo-electron microscopy have revealed 
complex organisation and assembly (Fiedorczuk et al., 2016; Guerrero-Castillo et al., 2017).  More 
recently, Complex I structure described in cryo-EM studies allowing mechanistic proposal for the 
Active/Deactivated transitions (Blaza et al., 2018; Parey et al., 2018; Zickermann et al., 2015). 
 
2 – Protein Assistance during Assembly 
There are approximately 15 proteins that act as assembly factors for complex I (Figure 1). 
Patients with mutations in complex I subunits and assembly factors have provided important 
information regarding the function of assembly factors and the assembly pathway along with 
bioinformatic and proteomic studies. The control of ND subunits mitochondrial gene expression is 
not well understood, only C20orf7 has been described as necessary for the maintenance of healthy 
steady state levels of ND1, but its specific function remains elusive (Sugiana et al., 2008). The 
assembly factor C8orf38/NDUFAF6 was identified by subtractive proteomics of purified 
mitochondria from a number of mouse tissues (Pagliarini et al., 2008). The function of this gene as 
an assembly factor was confirmed by the identification of a patient suffering from lethal infantile 
complex I deficiency due to a mutation in the gene. NDUFAF6 codes for a 333 amino-acid protein 
that is not present in all metazoans (Lemire, 2017).  As multi-subunit Complex I is not conserved in 
all eukaryotic organisms phylogenetic profiling and bioinformatic analysis has been used to identify 
unique genes. This approach identified the human orthologue of Neurospora crassa CIA30/NDUFAF1 
(Dunning et al., 2007). NDUFAF1 together with ECSIT helps the assembly of a sub-assembly 
intermediate containing the membrane arm subunits ND2, ND3, ND6 and NDUFB6 (Vogel et al., 
2007).  The B17.2L/NDUFAF2 gene was identified using a similar approach using whole genome 
subtraction of yeast strains lacking or containing complex I (Ogilvie et al., 2005). Identification of this 
complex I assembly factor coincided with the identification of a patient harbouring a mutation in this 
gene. B17.2L is a paralogue of the B17/NDUFB6 structural subunit of complex I that exists in the beta 
subcomplex that resides in the IMM (Vinothkumar et al., 2014).  NDUFAF2 is present in assembly 
intermediates with a proposed role as an important check-point in the assembly pathway (Mckenzie 
and Ryan, 2010). Another two factors NDUFAF3 and NDUFAF4 are proposed to have a role in early 
stages of the formation of the peripheral arm with the possible anchoring of the nuclearly encoded 
subunits NDUFS2, 3, 7, 8 and NDUFAF9 (Mckenzie and Ryan, 2010; Saada et al., 2009). Mutations in 
NDUFAF3 cause infantile lactic acidemia (Saada et al., 2009). Complex I activity requires the 
presence of iron-sulphur clusters in the N module in the subunits NDUFS1, NDUFS7, NDUFS8, 
NDUFV1, NDUFV2. Incorporation of Fe-S clusters are mediated by the assembly factor NUBPL/IND1. 
Mutations in NUBPL are associated with a number of Complex I diseases. The NDUFS7 subunit is 
hydroxylated on an arginine residue. This post-translational modification is mediated by NDUFAF5 
early in the assembly of complex I and this step is crucial for early steps on biogenesis of early 
assembly intermediates.  The FAD-dependent oxidoreductase domain containing protein (FOXRED1) 
is involved in steps part-way through Complex I assembly and is associated with certain Complex I 
deficiencies (Calvo et al., 2010; Formosa et al., 2015). 
  
3 – Modular Assembly 
Synthesis of mitochondrially encoded subunits can be followed by metabolic labelling using 
radioactive amino acids.  Newly synthesised mtDNA-encoded Complex I subunits assemble into a 
number of distinct membrane arm intermediates and require significant chase times for their 
integration into the holoenzyme. In contrast, nuclearly encoded subunits integrate with pre-existing 
Complex I subunits to form intermediates to assembly holoenzyme (Lazarou et al., 2007). Original 
studies into the assembly of Complex I made use of rho0 (Ugalde et al., 2004).  BN-page analyses of 
complex I sub-assembly intermediates in patient cell lines containing different Complex I mutations 
indicated that both matrix and membrane arm subunits are found together in early-stage 
intermediates of Complex I assembly process (Antonicka et al., 2003). With the more recent 
advances in mass spectrometry analysis new insights into the assembly of this complex multi-subunit 
enzyme have been revealed.  A complexome approach proposed a Complex I assembly pathway. 
Cells depleted of Complex I by treatment with chloramphenicol, a mitochondrial specific translation 
inhibitor, revealed a step-wise appearance of complexes that could be recognised using the 
composition of subunits as well as assembly factors.  Inhibition of mitochondrial translation depleted 
mitochondrial gene products, but could not deplete all nuclear encoded subunits, and these 
remained in complexes associated with the Q (ubiquinone electron transfer) and P (proton pumping) 
modules of the enzyme (Guerrero-Castillo et al., 2017).  Using systematic gene deletion of Complex I 
accessory subunits, 6 distinct modules of the enzyme were identified. Subunits displaying 
destabilisation after specific accessory subunit deletion were grouped together as this indicated a 
defect in assembly of that particular assembly module (Stroud et al., 2016) (Figure 1).  
The study of patients suffering from a variety of mitochondrial diseases caused by mutations 
in Complex I subunits has identified a number of sub-assemblies. A ND1 disease causing inversion 
mutation results in an altered sequence without any decrease in complex I expression, but results in 
decreased activity (Blakely et al., 2006). Other mutations in ND1 cause MELAS and hearing loss that 
result in decreased complex I activity and assembled enzyme without evidence of any sub-
assemblies (Gutiérrez Cortés et al., 2012; Kirby et al., 2004).  ND3 mutations causing infantile 
mitochondrial encephalopathy also displayed reduced expression of complex I but with a much 
larger impact on complex I activity implying mutations in this subunit affect activity much more than 
assembly of the complex (McFarland et al., 2004). ND6 mutations causing Leigh syndrome result in 
decreased amounts of complex I activity that also displayed two sub-assemblies detected by 
immunoblotting for subunits NDUFS5 and NDUFA9 (Ugalde et al., 2003). Mutations in ND4 are one 
of the most common causes of LHON, causing decreased activity of Complex I but little 
demonstration of sub-assemblies of Complex I biogenesis. Mutations of the other mitochondrial 
encoded complex I subunits, ND2, ND4L, and ND5, have been demonstrated to be causative for a 
variety of diseases, but analysis of sub-assemblies has not been performed.  
Several nuclear encoded Complex I core conserved subunits are responsible for disease 
when mutated and mitochondria from these patients express different sub-assemblies. Mutations in 
NDUFS7 cause Leigh syndrome which result in decreased Complex I activity and almost complete 
absence of assembled Complex I. This mutation in NDUFS7 also results in lack of expression of 
complex I subunits NDUFA13/GRIM19, NDUFA9 and NDUFS3, however there was no evidence of 
sub-assemblies (Lebon et al., 2007). Mitochondria derived from a separate patient with NDUFS7 
mutations displayed sub-assemblies containing NDUFA9, NDUFS3 and NDUFS5 (Ugalde et al., 2004). 
Differences in the presentation of disease in these two patients results from different mutations 
which has very different effects on complex I activity, perhaps indicating a difference in the 
association or function of the Fe-S cluster in this subunit. A mutation in NDUFS8 was found to cause 
late-onset Leigh syndrome and this resulted in decreased NDUFS8 expression along with other 
Complex I subunits NDUFS2, NDUFV1 and NDUFA9 indicating a general instability of the complex 
possible due to defects in assembly (Procaccio and Wallace, 2004). Mutations in NDUFB3 causing 
mitochondrial Complex I deficiency result in complete absence of Complex I containing 
supercomplexes and severe loss of Complex I activity (Haack et al., 2012). Mitochondria from 
fibroblasts derived patients with mutations in NDUFS2 that cause inherited Complex I deficiency 
display a number of sub-assemblies that contain NDUFS3 and NDUFS5 (Ugalde et al., 2004). 
Mutations in NDUFS4 associated with a Leigh-like syndrome also displayed sub-assemblies 
containing NDUFA9, NDUFS3, and NDUFS5 (Ugalde et al., 2004). Mutations in NDUFV1 characterised 
in the Complex I containing yeast, Yarrowia lypolytica, demonstrated the decreased expression and 
activity of fully assembled complex I along with increased amounts of ROS production (Varghese et 
al., 2015). NDUFS1 mutations result in isolated Complex I deficiency which result in decreased 
expression of fully assembled Complex I and also the presence of a sub-assembly containing NDUFA9 
that has a lower molecular size than fully assembled Complex I but is not catalytically active. Sub-
assemblies much lower in molecular size than assembled Complex I also exist when detected using 
NDUSF3 (Hoefs et al., 2010). NDUFS1 mutations that cause cavitative leukoencephalopathy result in 
decreased expression of several other subunits, including NDUFA9, NDUFS3, NDUFB8 and NDUFB4, 
resulting in decreased expression of fully assembled complex I (Ferreira et al., 2011). A destabilising 
mutation of NDUFA9 found in Leigh syndrome also causes decreased expression of 
NDUFA13/GRIM19 and NDUFB8, resulting in decreased complex I activity and expression, again 
indicating that certain subunits, such as NDUFA9, when absent exert effects on other subunits 
resulting in their decreased expression (van den Bosch et al., 2012). NDUFA2 mutations leading to 
destabilisation of NDUFA2 and NDUFA9 result in sub-assemblies containing NDUFA9 and NDUFS3 
(Hoefs et al., 2008). NDUFA1 mutations cause widespread decreased expression of a number of 
subunits (Potluri et al., 2009). A central nervous system specific deletion NDUFA5 in mice causes 
decreased expression of other Complex I subunits (Peralta et al., 2014). Patients with NDUFA6 
mutations display defects in complex I assembly and the presence of a late stage assembly 
intermediate lacking N-module subunits (Alston et al., 2018). Short interfering RNA inhibition of 
NDUFA11 expression leads to the decrease in assembled complex I and the accumulation of sub-
assemblies of the hydrophobic arm containing NDUFB8 (Andrews et al., 2013). Short hairpin 
mediated depletion of NDUFB11 in HeLa cells results in decreased expression of fully assembled 
complex I, decreased expression of other subunits and the presence of sub-assemblies containing 
NDUFS3 (van Rahden et al., 2015). NDUFA13/GRIM19 mutations are found in patients with early 
onset hypotonia, dyskinesia and sensorial deficiencies which is associated with decreased complex I 
assembly and destabilisation of subunits (Angebault et al., 2015). NDUFA10 mutations are associated 
with Leigh syndrome and cause decreased complex I assembly with a series of assembly 
intermediates containing NDUFS3 (Hoefs et al., 2011). Mutations in the structural subunit NDUFB8 
result in decreased activity and expression of the assembled Complex I enzyme, with no reported 
sub-assemblies (Piekutowska-Abramczuk et al., 2018). The accessory subunit NDUFAB1 (also known 
as the acyl carrier protein - ACP) is a vital protein and cells lacking this protein do not survive (Stroud 
et al., 2016). Mutations in NDUFV2, NDUFS6 are associated with disease but no evidence of effects 
on Complex I expression have been presented.   
Mutations in Complex I assembly factors are also responsible for a number of mitochondrial 
disorders and this has also given further insight into the assembly process. NDUFAF2 mutations lead 
to the accumulation of Complex I assembly intermediates and decreased expression of assembled 
Complex I (Hoefs et al., 2009). This assembly factor associates with several other assembly factors 
and structural subunits (Dunning et al., 2007; Fassone et al., 2011). A mutation in the assembly 
factor NDUFAF3 resulted in early childhood death due to a much reduced expression and activity of 
complex I.  NDUFAF4 mutations associated with infantile mitochondrial encephalopathy (Saada et 
al., 2009) and Leigh syndrome result in accumulation of sub-assemblies containing NDUSF3 
(Baertling et al., 2017).  Mutations in C20orf7/NDUFAF5 cause a lethal form of neonatal Complex I 
deficiency or Leigh syndrome (Gerards et al., 2010; Saada et al., 2012). When expression of 
NDUFAF5 is inhibited by RNA interference, Complex I activity is severely decreased, which is due to a 
decrease of fully assembled Complex I. This decrease is due to an inability to assemble Complex I in 
the absence of NDUFAF5 as newly synthesised subunits ND1 and ND2 are unable to assemble into 
Complex I (Sugiana et al., 2008). Depletion of NDUFAF5 also causes the disappearance of a Complex I 
sub-assembly containing NDUFS2 and the appearance of a normally low abundance sub-assembly 
containing NDUFB8 (Rhein et al., 2016).  
 
Complex II – Succinate Dehydrogenase 
Complex II (succinate dehydrogenase/succinate – co-enzyme Q reductase) is a highly 
conserved ETC complex that oxidises succinate as part of the citric acid cycle to pass electrons to co-
factors to flavin adenine nucleotide that are coupled to Fe-S clusters and co-enzyme Q reduction. 
Complex II is a 4 subunit complex that in eukaryotes is encoded completely by nuclear genes – the 
only OXPHOS complex to be expressed in this manner. Subunits SDHA/SDH1 and SDHB/SDH2 are 
catalytic subunits and reside in the complex facing the matrix which are anchored to the IMM 
through SDHC/SDH3 and SDHD/SDH4. Complex II harbours a haem prosthetic group between 
subunits SDHC and SDHD. The functional importance of this haem group is not known, but is 
required for assembly of the complex (Lemarie and Grimm, 2009). The assembly of complex II is 
mediated by a number of assembly factors similar to the other OXPHOS complexes (Figure 2).  
Diseases associated with mutations in SDH structural subunits and assembly factors result in 
paragangliomas and phaechromocytomas, and also Leigh syndrome. The first Complex II assembly 
factor, SDHAF1, was identified in patients with infantile leukoencephalopathy.  Patients with 
mutations in SDHAF1 have decreased amounts of assembled Complex II and also RNA interference 
reduces assembled Complex II in cell lines (Ghezzi et al., 2009). SDHAF1 is homologous to the yeast 
gene, SDH6, and can complement the corresponding deletion. SDHAF1 contains a LYR tripeptide 
motif that is associated with Fe-S homeostasis and is likely involved in Fe-S incorporation into 
Complex II. SDHAF1 function was confirmed to be required for Fe-S incorporation into SDHB through 
studies in yeast using the homologs SDH2 and SDH6. A second assembly SDHAF3 is also involved in 
Fe-S incorporation into SDHB (Na et al., 2014). The flavination of SDHA is mediated by SDHAF2 (SDH5 
in yeast) and mutation in this assembly factor is associated with paragangliomas (Hao et al., 2009).  
 
 
Complex III - Ubiquinol-cytochrome c oxidoreductase.  
 
1 - Structure 
Ubiquinol-cytochrome c oxidoreductase, or respiratory complex III, herein referred to as the 
bc1 complex is an integral multisubunit membrane enzyme that catalyses the transfer of reducing 
equivalents from ubiquinol to cytochrome c, coupling electron transfer to proton translocation across 
the IMM contributing for the formation of the electrochemical gradient, used for the synthesis of ATP 
by the mitochondrial F1-FO ATP synthase complex (Trumpower and Gennis, 1994).   
In Saccharomyces cerevisiae functional bc1 complex exists only in a dimeric form, with each 
monomer containing ten different subunits associated to the IMM (Hunte et al., 2000). Only the 
cytochrome b is encoded by the mitochondrial DNA, whereas the other nine proteins are nuclearly 
encoded.  Cytochrome b (Cobp) is the central core of the bc1 complex and together with cytochrome 
c1 (Cyt1p) and the Rieske Fe-S protein (Rip1p/UQCRFS1) are the redox centre, or catalytic subunits of 
the enzyme. Cobp is embedded via eight transmembrane spans in the inner membrane and harbours 
two redox centers: haem b562 (bH) and haem b565 (bL), which are located on distant positions in the 
membrane. Haem bL is positioned near the IMS, and haem bH is located in the interior of the enzyme, 
oriented towards the matrix space (Zara et al., 2009a).  The two haems groups are coordinated by 
histidine residues in a four-helix bundle (Hunte et al., 2000).  Cyt1p contains haem c1 as its redox center 
exposed in the IMS. Rip1p presents a topology similar to Cyt1p, with a mobile catalytic domain in the 
IMS and a hydrophobic α helix bound to the inner membrane (Hunte et al., 2000).  
The bc1 complex couples electron transfer to proton shuttling by a mechanism known as the 
Q-cycle (Mitchell, 1975).  In a bifurcated reaction (Trumpower, 2002), one electron is delivered from 
ubiquinone at the quinone oxidation (QO) site to Rip1p and Cyt1p, which reduces soluble cytochrome 
c in the IMS. Indeed, Rip1p cycles between two conformational states to transfer electrons from the 
ubiquinone bound in the QO site to Cyt1p (Brugna et al., 2000) a very important feature for this 
mechanism to work is the large scale domain movement of Rip1p (Rathore et al., 2019; Zhang et al., 
1998). The second electron passes through haem bH and haem bL in Cobp, reducing ubiquinone to 
semi-ubiquinone at the quinone reduction (Qi) site at the matrix side of the membrane (Trumpower, 
1990). As a result, two protons are released at the IMS per electron transferred to cytochrome c. 
Interestingly, cytochrome c binds to the homodimeric bc1 complex in a monovalent mode, the binding 
correlates with a conformational change of the Rip1p head domain and subunit Qcr6p in one 
monomer turning the dimer into an asymmetric form (Solmaz and Hunte, 2008).  Indeed, Rip1p 
physically cross-links the two functional units of the intertwined dimer and probably act as a 
regulatory element in the mechanistic alternating site model, with only one monomer of the bc1 
complex active at a time (Solmaz and Hunte, 2008). The understanding of the structure and function 
of this complex has furthered by high resolution cryo-EM of the bc1 complex dimer revealing 12 
phospholipid molecules including four phosphatidylcholines, four phosphatidylethanolamines, two 
cardiolipins, and two 1,2-diacyl-sn-glycero-3-phoshocholines (Rathore et al., 2019). There are two 
classes of specific bc1 complex inhibitors: the first class inhibits the electron transfer at the QO site and 
includes stigmatellin and myxothiazol (von Jagow et al., 1984), the second class exemplified by 
antimycin A (Wikström and Berden, 1972), block the Qi site by interrupting the electron transfer from 
haem bH to quinone or semiquinone.   
In addition to the three catalytic subunits, the other seven structural subunits are referred to 
as supernumerary subunits, which include Cor1p, Cor2p, Qcr6p, Qcr7p, Qcr8p, Qcr9p and Qcr10p.  All 
subunits, except for Qcr6p and Qcr10p, they are essential for yeast respiration.  
Cor1p and Cor2p are the two largest subunits of the complex and were named core proteins 
on the assumption that they would form the core of the complex. COR1 codes for the 44-kDa core 
protein, which is the largest subunit of the bc1 complex (Tzagoloff et al., 1986). The protein is bound 
to the IMM but mostly is exposed to the mitochondrial matrix, where it interacts with Cor2p and Qcr7p 
(Hartley et al., 2019; Rathore et al., 2019).  
Qcr6p is an acidic subunit that assists Cyt1p association into the complex (Yang and 
Trumpower, 1994) and cytochrome c binding to the homodimeric bc1 complex (Solmaz and Hunte, 
2008). The protein is loosely associated with the complex since it is easily released into the 
intermembrane space. Indeed, qcr6 yeast mutants grow normally on a non-fermentable substrate 
(Crivellone et al., 1988).  
Qcr8p, Qcr9p and Qcr10p are small proteins that cross the IMM with a hydrophobic α-helix 
(Brandt et al., 1994; Maarse and Grivell, 1987; Schmitt et al., 1990). The structure and peripheral 
binding of Qcr10p to the bc1 complex could only be recently resolved in cryo-EM structure studies 
(Hartley et al., 2019; Rathore et al., 2019).  In the matrix, the extended N terminus of Qcr10p interacts 
with Cor2p and Qcr7p of the other monomer, while in the IMS Qcr10p interacts with Cyt1p (Hartley 
et al., 2019). An eleventh subunit present in the human complex turned out to be the leader sequence 
of Rip1, which is retained within the mature complex (Brandt et al., 1993). 
 
2 - Mitochondrial Gene expression 
The COB gene of yeast mitochondria contains two, or three and in some cases as many as six 
introns (Lazowska et al., 1980; Nobrega and Tzagoloff, 1980). Some introns code for splicing factors 
that promotes the excision of their own coding sequences whereas other depends on nuclear encoded 
products. For instance, the terminal intron (bI2) is a group I intron, capable of self-splicing in vitro but 
dependent of the Cbp2 protein in vivo (Gampel et al., 1989). Mrs1p and Mss116p are also nuclear 
encoded proteins required for COB intron removal, however they are also necessary for intron 
processing in other mitochondrial genes, indeed, Mss116p has a RNA chaperone function that belongs 
to the DEAD-box protein family, and it is required for efficient splicing of all mitochondrial group I and 
group II introns present in COX1, COB and 21S rRNA, as well as for mitoribosome biogenesis and COX1 
translation (De Silva et al., 2017; Huang et al., 2005; Kreike et al., 1986). The bicistronic COB primary 
transcript also contains the tRNA E coding sequence, which is processed by RNase P along with 
auxiliary proteins (Guedes-Monteiro et al., 2019). The 5’ end of COB RNA is further processed by 
Pet127p and finally stabilized by Cbp1p within the AU-rich COB mRNA 5’-UTR that contains a unique 
CCG trinucleotide (Chen and Dieckmann, 1997; Dieckmann et al., 1984; Fekete et al., 2008; 
Mittelmeier and Dieckmann, 1993).   
The dependence on two separated genomes for proper assembly of the respiratory complexes 
required the development of a balanced output of gene products destined to be subunits of the same 
enzyme. Mitochondria translational activators are the primary candidates to exert such control 
(Costanzo and Fox, 1990) in three proposed ways:  through the recognition of a specific 5’ UTR end, 
which is the case of Cbp1p, Cbs1p and Cbs2p; by a direct interaction with the mitoribosome (Cbs1p, 
Cbs2p, Cbp3p and Cbp6p); and finally interacting with the nascent polypeptide chain at the 
mitoribosome tunnel exit (Cbp3p and Cbp6p) (Derbikova et al., 2018; Ndi et al., 2018). 
Besides its function on mRNA stabilization Cbp1p might also play a role in co-translational 
insertion of Cobp into the inner membrane (Krause et al., 2004). Cbs1p and Cbs2p were shown to 
interact with the 5’ UTR of COB mRNA as well as with the mitoribosome itself (Krause-Buchholz et al., 
2005, 2004; Rödel and Fox, 1987; Rödel, 1986). Cbp3p and Cbp6p are involved in a feedback loop 
mechanism required for the coordination of Cobp synthesis and assembly (Dieckmann and Tzagoloff, 
1985; Gruschke et al., 2012, 2011). It has been proposed that the Cbp3p-Cbp6p complex associates 
with newly synthesized protein preventing apocytochrome b from degradation and assist the early 
steps of bc1 complex assembly (Gruschke et al., 2012).  Upon early failure in bc1 biogenesis, Cbp3p-
Cbp6p remains associated with the intermediate and is not available to stimulate a further round of 
COB mRNA translation (Hildenbeutel et al., 2014). 
 
3 – Protein Assistance in the Assembly process 
Yeast mutants of bc1 complex were isolated in terms of the activity of the electron transfer 
complexes, ATP synthase activity and cytochrome spectra. Hallmarks of these mutants include 
absence of the characteristic spectra of mitochondrial cytochrome b, and specific reduced activity of 
NADH or CoQH2 – dependent reduction of cytochrome c in the presence of cyanide (Tzagoloff and 
Dieckmann, 1990; Tzagoloff, 1995). 
Numerous assembly factors are required for proper bc1 assembly. They assist the modular 
assembly of the complex as well as maturation and topogenesis of the prothestic groups present in 
Cobp, Cyt1p and Rip1p proteins (Ndi et al., 2018; Smith et al., 2012). 
Besides their role in Cobp translation, Cbp3p and Cbp6p are chaperones of the newly 
synthesized Cobp, which is a crucial step for Cobp maturation. Indeed, null mutants of cbp3 or cbp6 
are still able to translate Cobp at a reduced rate but the protein is rapidly degraded (Gruschke et al., 
2011). Cbp4p is also a chaperone essential in the process of bc1 biogenesis; the protein is tightly 
associated with the mitochondrial membrane (Crivellone, 1994) and it is required for Cobp 
stabilization during the haemylation process of apocytochrome b  (Hildenbeutel et al., 2014). 
The haem c addition to Cyt1p is also a protein-assisted process. Cyt1p has a bipartite signal 
sequence. The first part is removed by the mitochondrial processing peptidase (MPP) in the matrix; 
secondly, Imp2p only performed the removal of the remaining presequence after the covalent 
addition of haem c (Arnold et al., 1998a). The covalent attachment of haem c1 to apocytochrome c1 is 
assisted by Cyt2p a haem lyase (Zollner et al., 1992). In certain cyt1 mutants and in the absence of 
Cyt2p the haem lyase function can be performed by Cyc3p, the haem lyase of soluble cytochrome c 
(Bernard et al., 2003). HCCS is the human Cyt2p homolog and covalently links a haem group to the 
apoprotein of cytochrome c. 
Bcs1p and Mzm1p are both necessary for the maturation and insertion of Rip1p into the bc1 
complex. Mzm1p stabilizes Rip1p Fe-S cluster in the mitochondrial matrix, protecting it from 
aggregation and degradation prior to integration and association with Bcs1p into the IMM (Atkinson 
et al., 2011; Cui et al., 2012). The AAA ATPase Bcs1p mediates Rip1p translocation with its bound Fe-
S cluster across the IMM from the mitochondrial matrix (Cruciat et al., 1999; Nobrega et al., 1992; 
Wagener et al., 2011). Bcs1p has a single transmembrane domain near the N-terminus spanning the 
IMM, which is crucial for the assembly of Rip1p into the bc1 complex (Sawamura et al., 2014). 
Downstream of the N-terminal transmembrane region the protein is divided into three regions: a non-
canonical mitochondrial-targeting signal just following the transmembrane region, a AAA ATPase and 
a highly conserved middle domain of unknown function (Fölsch et al., 1996; Ndi et al., 2018). 
  Finally, Bca1p is present only in fungi; it is bound to the IMM and protrudes into the IMS. Its 
specific function is still unknown, but it seems necessary in early assembly steps of bc1 assembly 
process (Mathieu et al., 2011). 
 
4 - Modular Assembly 
Biogenesis of the bc1 complex was recently scrutinised in five different stable intermediates 
that are observed from Cobp mitochondrial translation and IMM insertion to Rip1p addition to the 
dimeric complex (Ndi et al., 2018) (Figure 3). 
The newly synthesized Cobp protein is rapidly associated to the Cbp3p-Cbp6p complex, which 
is bound to the tunnel exit of the mitochondrial ribosome, the association of apocytochrome b with 
Cpb3p-Cbp6p release the complex from the ribosome (Gruschke et al., 2011). 
The first proposed intermediate is formed after hemylation of apocytochrome b, which occurs 
in a two-step process. The first haem b is inserted at the bL site favouring the binding of Cbp4p, which 
allow the addition of the second haem b at the bH site and subsequent release of Cbp3p-Cbp6p 
(Hildenbeutel et al., 2014). The mature Cobp associates with Qcr7p and Qcr8p subunits forming the 
second intermediate (Gruschke et al., 2012; Ndi et al., 2018; Zara et al., 2009b).  
 The subsequent association of Cobp-Qcr7p-Qcr8p-Cbp4p with Cor1p and Cor2p lead to Cbp4p 
dissociation, and the association with matured Cyt1p and Qcr6p (Gruschke et al., 2012), forming the 
third intermediate of about 500kDa (Zara et al., 2007). The addition of Qcr9p and the recruitment of 
Bcs1p generate the fourth intermediate. As described before, Bcs1p assists the insertion of the Fe-S 
protein Rip1p into the precomplex and, consequently, the formation of the fifth intermediate. Qcr9p 
binds to the transmembrane segment of Rip1p, integrating Rip1p firmly into the precomplex (Rathore 
et al., 2019). Binding of Bcs1p to and release from the cytochrome bc1 precomplex appears to be a 
dynamic process regulated by ATP hydrolysis (Cruciat et al., 1999), therefore, Bcs1p dissociation and 
perhaps Qcr10p binding at this step ends the process with the formation of mature bc1 complex (Ndi 
et al., 2018).    
 The dimerization process is an early event in the bc1 biogenesis. Indeed, it was demonstrated 
that the bc1 late core intermediate lacking Rip1p possesses a dimeric structure excluding a potential 
role of this catalytic protein in the dimerization process (Conte et al., 2015). It is plausible that 
dimerization occurs just after the addition of haem b into Cobp protein, or Cbp4p dissociation (Ndi et 
al., 2018). 
In a recent study it was shown a spatial compartmentalization of mitochondrial translation 
and the assembly of the respiratory complexes through the identification of different sites of the IMM 
sites: the inner boundary membrane (IBM), which parallels the outer membrane, and the cristae 
membrane (CM) (Stoldt et al., 2018). The modular assembly of the bc1 complex begins with 
mitochondrial Cobp translation at IBM, the association with Cbp3p-Cbp6p also occurs mainly at this 
site, but the association of Cbp4p, an intermediate phase event, is less enriched at IBM; on the other 
hand factors involved in late assembly events, such as Bcs1p, are enriched at CM (Stoldt et al., 2018), 
which shows a distinct spatial distribution of the different assembly steps of the bc1 complex.  
Deficiencies in bc1 complex are the least common oxidative phosphorylation defects 
associated with mitochondrial disease. Mutations in the mitochondrial CYB gene have been so far 
described in 45 different positions (MITOMAP). Patients with mutations in nine nuclear genes required 
for bc1 assembly have also been reported presenting a wide range of tissue-specific defects   including 
the structural components UQCRQB, UQCRQ and UQCRC2 and the accessory factors BCS1L, TTC19, 
LYRM7, UQCC1,  UQCC2 and UQCC3 (Ghezzi and Zeviani, 2018; Gorman et al., 2016). Defective BCS1L 
is the most frequent cause of CIII-defective mitochondrial disease, as more than 25 different 
pathological mutations associated to very variable clinical presentations ranging from multivisceral 
GRACILE to congenital metabolic acidosis, neonatal proximal tubulopathy and/or liver failure with or 
without encephalopathy (Fernández-Vizarra and Zeviani, 2015) CYC1 mutations present ketoacidotic 
and lactic acidotic encephalopathy and insulin-responsive hyperglycemia (Gaignard et al., 2013). 
TTC19 is only found in metazoans and probably function as a scaffold for bc1 complex 
biogenesis, in its absence a subcomplex containing Cor1/Cor2 is accumulated (Smith et al., 2012). 
LYRM7 is the human Mzm1p counterpart required for the stabilization of UQCRFS1 (Sánchez et al., 
2013). UQCC1, UQCC2 and UQCC3 are the human othologs for yeast Cbp3p, Cbp6p and Cbp4p 
respectively. UQCC1 binds to newly synthesized Cyt b and is required for UQCC2 function (Tucker et 
al., 2013; Wanschers et al., 2014). 
 
5 - Supercomplex with cytochrome c oxidase 
The use of mild detergents for mitochondrial protein solubilization revealed that respiratory 
chain complexes form supramolecular assemblies known as supercomplexes, which composition and 
abundance may vary among organisms and tissues depending on the metabolic and physiological 
conditions (Lobo-Jarne and Ugalde, 2018).  In yeast the bc1 complex dimers associate with either one 
or two copies of mature cytochrome c oxidase to form supercomplexes of the respiratory chain 
(Cruciat et al., 2000; Schägger and Pfeiffer, 2000). Although, the physiological importance of 
supercomplex formation has not yet been determined, their presence and higher distribution in the 
inner membrane cristae (Stoldt et al., 2018) can maximize the proton gradient and therefore the 
efficiency of the oxidative phosphorylation process. In mammalian mitochondria the respiratory 
supercomplexes  also harbour complex I and is termed the respirasome since they contain all the 
components required to transfer electrons from NADH to molecular oxygen. The most abundant form 
of respirasome in mammalian cells consists of one unit of complex I, the dimeric complex III and one 
unit of complex IV (Lobo-Jarne and Ugalde, 2018).  In yeast the supercomplexes are stabilized by 
cardiolipin and phosphatidylethanolamine (Pfeiffer et al., 2003) and at least three proteins: Rcf1p, 
Rcf2p and Coi1p (Singhal et al., 2017; Strogolova et al., 2019, 2012; Vukotic et al., 2012). 
Cryo-EM studies revealed protein–protein interactions in the interface of bc1–COX on either 
side of the IMM and interactions via bridging lipids in the membrane region itself (Hartley et al., 2019; 
Rathore et al., 2019). The majority of electrostatic interactions occur on the matrix side between 
Cor1p and Q residues at the N terminus of Cox5ap in a combination of hydrogen bonds, for example 
between K240--Q46, D192--Q35, via Cor1p K239 ε amino group with the side-chain carbonyl of Q47, 
and a pi-pi stacking interaction between the aromatic rings of Cor1p Y65 with Cox5ap W38 (Hartley et 
al., 2019; Rathore et al., 2019). In the IMS, the C-terminal domain of Cox5ap is in position to interact 
with both the C terminus of Qcr6p and a loop region between helices 6 and 7 of cytochrome c1. Within 
the membrane, Cox5ap contacts the N-terminal helix of Rip1p and Qcr8p via a cardiolipin molecule 
and another lipid modelled as phosphocholine (Hartley et al., 2019). 
 
Complex IV – Cytochrome c oxidase 
1 – Structure and function 
Cytochrome c oxidase (COX) is the terminal electron acceptor in the ETC of many organisms.  In 
the case of organisms that use molecular oxygen as the terminal electron acceptor COX accepts 
electrons from cytochrome c and uses this to reduce molecular oxygen to water.  We will only 
consider eukaryotic terminal electron acceptors of this nature.  Other terminal electron acceptors 
and alternative oxidases exists and are mainly found in bacteria and plants.  COX is composed of 
three catalytic core subunits, and in most cases, these subunits are encoded by mitochondrial DNA.  
The remaining subunits and assembly factors are encoded by genes present in the nucleus, but the 
number of these varies between organisms which will be highlighted here.   
Many of the structural subunits and assembly factors of COX were identified in Saccharomyces 
cerevisiae and functions have been elucidated since.  More recently, large-scale genomic analysis of 
patients and proteomic approaches have revealed new proteins associated with COX assembly and 
function. Structural studies initially carried out using bovine heart COX determined the 3-
dimensional organisation of structural subunits and co-factors that has informed the catalytic 
mechanism of the enzyme as well as the proton channelling required to contribute to the generation 
of the mitochondrial membrane potential (Tsukihara et al., 1996). The conservation of COX 
structural subunits from many organisms is high and this allows for interpretation of all sources of 
COX. The subunit contacts within COX are predicted to be conserved based on the conserved 
function of the enzyme (Hartley et al., 2019; Rathore et al., 2019).  Knowledge of the subunit 
contacts allows for predictions of which subunits should interact as the enzyme is undergoing 
assembly. In higher eukaryotes, COX has a conserved structure with homologous subunits found in 
yeast.  Complexity is increased due to the presence of more structural subunits, subunit isoforms 
and differential regulation of expression and assembly using different mechanisms.  Studies related 
to the assembly of COX in higher eukaryotes initially came about after human genetic studies of 
patients suffering from mitochondrial diseases.  The absence of any vital structural subunit in 
humans would be expected to result in a non-viable embryo/foetus or a severe disorder. Many 
mutations in COX subunits and assembly factors have been identified over the years, that result in 
lower activity or expression of the functional enzyme, indicating an inefficiency in biogenesis or 
function.  Mutations in the mitochondrial-encoded COX subunits are associated with mitochondrial 
disease, such as Leber’s Optic Atrophy and Complex IV deficiency syndromes (COX6B1, COX7, 
COX8A, MTCO1, MTCO2, MTCO3). Mutations in structural subunits leading to COX deficiency 
syndromes have more than one isoform (COX6A, COX6B, COX7) which may be compensated by 
inappropriate expression of the isoform in the defective tissue or are derived from mitochondrial 
DNA where heterogeneity of mitochondrial mutations can be variable (Rak et al., 2016).   
 
2 - Mitochondrial Gene Expression 
The three COX mitochondrial-encoded genes have specific protein factors involved in regulating 
their expression and translation. In yeast, COX1 is transcribed as a polycistronic transcript containing 
ATP6/ATP8 of ATP synthase (Manon and Guerin, 1989). Transcript processing requires splicing to 
generate a COX1 transcript without introns, a process assisted by maturases encoded by open 
reading frames located within some of the introns (Lazowska et al., 1980) and nuclear genes such as 
MSS116 and COX24  (Barros et al., 2006; Séraphin et al., 1989), which are curiously also involved in 
mitoribosome biogenesis (De Silva et al., 2017; Mays et al., 2019).  Indeed, some of these factors 
have several functions in mitochondrial RNA metabolism. For instance, the COX1 specific 
translational activator, Pet309p, binds to COX1 messenger RNA prior to processing of the 
polycistronic mRNA - an interaction that depends on the pentatricopeptide repeat (PPR) motifs 
(Zamudio-Ochoa et al., 2014) and - is also required for translation (Tavares-Carreón et al., 2008). 
Translation of the mature COX1 transcript is controlled by a post-transcriptional mechanism reliant 
on the function of Mss51p, a translational activator.  Mss51p, when free, associates with COX1 
mRNA and promotes translation (Barrientos et al., 2004). Mss51p function is regulated by the 
presence of haem and Mss51p mutants that cannot bind to haem or when cells are depleted of 
haem, Mss51p cannot act as a translational activator of COX1 mRNA (Soto et al., 2012). Mss51p is 
also part of Cox1p assembly complexes (see later) that sequester Mss51p and prevent it from acting 
as a translational activator. COX2 mRNA associates with Pet111p which binds to a site in the 5’ 
untranslated region (UTR) and a site in the coding sequence. Pet111p acts as a translational activator 
potentially by preventing the formation of secondary structure in the translation initiation region 
(Jones et al., 2019).  COX3 mRNA interacts with Pet54p, Pet122p and Pet494p, which are all 
translational activators of the COX3 mRNA transcript and associate in the 5’ UTR (Costanzo and Fox, 
1988, 1986; Costanzo et al., 1986). These are present in an IMM associated complex that interacts 
with the ribosome to enable translation of COX3 mRNA (Brown et al., 1994). Interestingly, Pet54p 
also interacts with COX1 mRNA to allow for intron splicing but also efficient translation (Mayorga et 
al., 2016; Valencik et al., 1989). As a mechanism to co-ordinate translation of these three COX 
mitochondrial mRNAs, a complex of translational activators has been described (Naithani et al., 
2003) and translation has been visualised occurring at specific intra-mitochondrial sites (Stoldt et al., 
2018). Translation of mitochondrial COX transcripts is dependent on the function of mitochondrial 
ribosome subunits, such as COX24/mS38 and mL38 (Box et al., 2017; Mays et al., 2019). These point 
to a highly co-ordinated system to regulate COX subunit translation within mitochondria to enable 
efficient biogenesis.   
 
3 – Protein Assistance in the Assembly Process 
Protein assistance is required at all stages of the assembly process including the insertion of 
highly hydrophobic mitochondrially encoded components, as well as the maturation of their catalytic 
subunits through addition of two haem group and three copper prosthetic groups (Barrientos et al., 
2002). COX subunit I (Cox1p) is a 12 trans-membrane domain spanning integral IMM protein.  This 
catalytic core subunit contains the haem groups from cytochrome a and a3 and a copper ion in the 
CuB centre required for COX electron transfer as the catalytic site for reduction of molecular oxygen 
to water. The low spin haem a and the high spin a3 are non-covalently bound to Cox1p and are 
synthesized from protoheme by the addition of a farnesyl group by Cox10 a farnesyl transferase 
(Tzagoloff et al., 1993), followed by a monoxygenase reaction catalysed by Yah1p-Cox15p (Barros et 
al., 2002, 2001). The final hemylation of Cox1p is still elusive, however it depends on Cox10p and 
Cox15p oligomerization (Bestwick et al., 2010; Khalimonchuk et al., 2012) and additional factors such 
as Coa2p, Shy1p and Pet117p (Kim et al., 2012; Taylor et al., 2017). Cox1p is translated and inserted 
in to the IMM by Oxa1p, Mba1p and Mrx15p IMM insertases (Hell et al., 2001; Möller-Hergt et al., 
2018; Preuss et al., 2001) most likely through specific juxta-membrane localisation of mitochondrial 
ribosomes.  When in the IMM, Cox1p is then part of a complex containing Coa1p, Coa3p/Cox25p and 
Cox14p (Fontanesi et al., 2011; McStay et al., 2013a, 2013b; Mick et al., 2010; Pierrel et al., 2007).  
These three assembly factors are single trans-membrane domain spanning integral IMM proteins 
whose functions are unknown but essential for COX biogenesis.  This complex then recruits Mss51p 
and the first structural subunit Cox5ap/bp.  In this complex, Mss51p is sequestered away from COX1 
mRNA and is unavailable for further activation of translation.  This epistatic mechanism of regulation 
ensures that further biogenesis of Cox1p cannot occur in the absence of required assembly factors, 
structural subunits or prosthetic groups, such as haem and copper.  There are two homologous 
genes for COX subunit 5, COX5A and COX5B, which are 66-67% homologous at both the nucleotide 
and amino acid sequence (Cumsky et al., 1985).  The difference between these two genes is how 
gene expression is regulated.  COX5A is the major transcription product under conditions of 
normoxia, while COX5B is the major transcription product under conditions of hypoxia (Hodge et al., 
1989).  Incorporation of Cox5bp into COX provides an increased affinity for molecular oxygen to 
allow OXPHOS to continue under hypoxic conditions.  Cox5a/bp are trans-membrane proteins that 
display associations only with Cox1p in the fully assembled COX enzyme based on structural studies 
in mammalian and yeast COX (Tsukihara et al., 1996). In yeast, COX5 is the only COX subunit to have 
alternative isoforms and potentially incorporation of this subunit allows for altered biogenesis or 
overall assembled structure that enables increased affinity for oxygen.  In higher eukaryotes, other 
structural subunits have multiple isoforms giving rise to greater structural and functional diversity. 
This discrete assembly complex was identified using affinity purification of these aforementioned 
assembly factors and structural subunits to identify associated mitochondrial gene products that 
were metabolically labelled. These complexes only contained newly synthesised Cox1p and there is 
no evidence of newly synthesised Cox2p or Cox3p indicating a discrete assembly pathway of Cox1p 
prior to association of other catalytic core subunits of COX. The maturing Cox1p sub-complex then 
recruits Cox6p and Cox8p, both structural subunits associated with the final assembled COX enzyme 
(McStay et al., 2013a). Cox8p is another single trans-membrane spanning subunit that is encoded by 
the nuclear genome. Cox6p is the only peripheral membrane structural subunit of COX which resides 
on the matrix facing side of the IMM.  The next sub-complex is formed by the addition of Shy1p, an 
assembly factor that has been implicated in haem addition to assembling COX (McStay et al., 2013b).  
Shy1p is a multi-trans-membrane spanning protein.  Interestingly, Shy1p is a homolog to all related 
forms of the COX enzymes from bacteria to humans, indicating its importance in COX biogenesis, 
and is most likely one of the most fundamental proteins required for COX assembly (Greiner et al., 
2008). Copper is the other required co-factor for Cox1p. Incorporation of copper into Cox1p is 
mediated by the copper chaperones Cox17p (Glerum et al., 1996a) and Cox11p (Hiser et al., 2000; 
Khalimonchuk et al., 2005; Tzagoloff et al., 1990). Like Cox17p, other soluble factors such as Cmc1p, 
Cox19p, and Cox23p also contain a CX9C motif and are required for the maturation of Cox1p copper 
centre (Barros et al., 2004; Bode et al., 2015; Bourens and Barrientos, 2017; Dela Cruz et al., 2016; 
Horn et al., 2008; Khalimonchuk et al., 2010; Nobrega et al., 2002). 
The other two catalytic core subunits of COX, Cox2p and Cox3p are both trans-membrane 
spanning domain proteins.  Cox2p has two trans-membrane spanning domains and has an 
associated copper co-factor in the CuA binuclear centre that accepts electrons delivered by 
cytochrome c. Cox3p has a single trans-membrane domain with no co-factors or prosthetic groups 
but is thought to participate in proton translocation. Cox2p is the only mitochondrial genome 
encoded structural subunit that requires proteolytic processing before incorporation into COX.  
Amino-terminal processing removes the first 15 amino acids from the polypeptide and this occurs 
before association with Cox2p assembly factors. The inner membrane peptide complex catalytic 
subunit Imp1p is responsible for the removal of the propeptide (Behrens et al., 1991; Pratje et al., 
1983). Cox20p associates with the Cox2p pre-cursor prior to cleavage by Imp1p (Hell et al., 2000). 
Cox18p acts to assist with the entry of the Cox2p C-terminus into the IMM in association with Pnt1p 
and Mss2p (Lode et al., 2000; Pacheu-Grau et al., 2015; Saracco and Fox, 2002; Schulze and Rödel, 
1988).  Copper does not reside freely in yeast and is in complex with the copper chaperone Cox17p 
that delivers copper to Cox11p for to incorporate into Cox1p (Cobine et al., 2006; Hiser et al., 2000; 
Jett and Leary, 2017). The formation of the binuclear CuA center depends on Sco1p, which contains 
bound copper (Beers et al., 2002) and probably transfer its copper to the CuA site (Glerum et al., 
1996b), as well as alter the oxidation state of the cysteine ligands in Cox2p  (Chinenov, 2000). The 
yeast paralog Sco2p is probably the human SCO1 counterpart and is not required for COX assembly.  
In contrast, human patients with mutations in either SCO1 or SCO2 present a COX deficiency that 
cannot be rescued by the respective homolog, indicating non-overlapping activities of the two 
proteins (Leary et al., 2007). Accordingly, while one Sco protein promotes maturation of the CuA 
site, the second regulates copper efflux under conditions of excessive cellular copper (Leary et al., 
2007). Coa6 is an additional factor that together with human SCO2 promote the maturation of the 
CuA center (Pacheu-Grau et al., 2015).  Interestingly, newly synthesised Cox2p does not make 
associations with any structural subunits until the Cox1p or Cox2p assembly modules associate. 
Indeed, Cox2p assembly intermediates were mainly found associated to Cox18p and Cox20p, and a 
small fraction with Sco1p and Coa6p  (Franco et al., 2018). Cox16p has been detected in both Cox1p 
and Sco2p-Cox2p assembly complexes and has been proposed to be assembly factor involved in the 
association of Cox1p and Cox2p assembly modules (Aich et al., 2018; Cerqua et al., 2018; Su and 
Tzagoloff, 2017).  The structural subunits, Cox9p and Cox12p, would be hypothesised to associate 
with Cox2p based on the structure of the final assembled COX enzyme, but the association of Cox9p 
and Cox12p with any COX catalytic subunit assembly modules has not been observed (Franco et al., 
2018; Su et al., 2014a).  Newly synthesised Cox3p associates with the structural subunits found in 
the final assembled enzyme (Cox4p, Cox7p, Cox13p) and Rcf1p, a protein involved in supercomplex 
formation with complex III (Chen et al., 2012; Strogolova et al., 2012; Su et al., 2014a; Vukotic et al., 
2012).  
There are still unanswered questions that need to be addressed in the assembly of yeast 
COX. There are still several subunits and assembly factors that have not been observed to associate 
with newly synthesised catalytic core subunits, e.g., Cox9p, Cox12p. The steps where haem and 
copper are incorporated into the assembling COX enzyme has not been directly demonstrated. 
Proteins associated with incorporation these co-factors are known, for the case of Shy1p with Cox1p 
and Sco1p with Cox2p. However, these complexes have not been directly analysed for content of the 
appropriate co-factor.  The final association of the three distinct assembly modules is also not 
known. Some of these unanswered questions may be due to limitations of the experimental 
technique where assembly is being followed in vitro where limiting factors may be absent or 
sensitivity to detergents may result in disruption of associations.   
Some very interesting observations from the analysis of the assembly process require follow 
up. OXPHOS complexes are known to exist in supercomplexes, thought to promote efficient transfer 
of electrons from one complex to another which also decreases the opportunity for electron loss 
resulting in dangerous radicals in the cell. Cox6p associated with newly synthesised Atp9p, which 
forms the rotor component assembly module of ATP synthase. The association of Cox6p with Atp9p 
is independent of the requirement to for COX or ATP synthase, as mutants unable to form either of 
these complexes are able to form these complexes. This demonstrates a cross-talk between these 
OXPHOS complexes during biogenesis. The reason for the existence of this interaction has not yet 
been elucidated (Su et al., 2014b). The associations of assembly factors with COX structural subunits 
is thought to be transient to enable a required step in biogenesis to occur. However, prolonged 
associations with Shy1p and Cox16p in assembling and fully assembled COX have been observed 
(McStay et al., 2013b; Su and Tzagoloff, 2017). The purpose of these associations with fully 
assembled COX has not been investigated. Potential functions could be to mark newly synthesised 
COX or in maintenance of assembled COX.  The formation of a fully assembled COX in organello is 
observed by BN-PAGE and 2D SDS-PAGE. However, the stoichiometry of catalytic core subunits is not 
representative of an equal amount of newly synthesised complex being present in the complex. 
Assembled COX after in organello labelling was composed of only newly synthesised Cox2p and 
Cox3p, with very minimal amounts of newly synthesised Cox1p (McStay et al., 2013b). This indicates 
there is a source of Cox1p within mitochondria that is primed and ready to be incorporated into COX 
when there are sufficient amounts of Cox2p and Cox3p. This perhaps indicates that Cox1p exists in a 
complex where haem and copper are already associated and awaits the synthesis of Cox2p and 
Cox3p. Cox1p containing complexes not part of fully assembled COX have been detected in yeast 
mitochondria and these could potentially represent a supply of pre-formed Cox1p modules awaiting 
incorporation into the fully formed enzyme. The complexity of the Cox1p subunit structure and 
requirements for associated co-factors and structural subunits supports this hypothesis. The number 
of steps required for Cox1p biogenesis may be rate-limiting and result in slow assembly of COX or 
present reactive intermediates that could result in electron leakage. However, this needs to be 
investigated in much more detail using in vivo conditions that may be more representative of normal 
physiological conditions.    
The COX assembly process has been studied extensively in model organisms as well as using 
mitochondrial disease patient samples providing insights into the process in humans.  This work has 
revealed many similarities but also many differences between the yeast and higher eukaryotic 
systems of COX assembly.  Mutations in human COX assembly factor genes give rise to disease 
(COA3/MITRAC12, COA7, COA8/APOPT1, COX20, SCO1, COX10, TACO1, PET100). Fatal infantile 
encephalocardiomyopathy is caused by mutations in SCO2, COX15, COA5, and COA6; and Leigh 
Syndrome by mutations in SURF1, COX10, COX15, TACO1, PET100, and LRPPRC.   
Regulation of mitochondrial gene expression relies heavily on post-transcriptional steps.  
Mutations in the mammalian MTCO1 translational activator TACO1 are responsible for certain forms 
of Leigh Syndrome.  Fibroblasts derived from these patients express novel complexes containing COX 
subunits. TACO1 mutation results in decreased translation of MTCO1, implying the novel complex is 
lacking MTCO1.  Expression of MTCO2 and MTCO3 is also decreased, however translation occurs but 
theses subunits have decreased stability indicating the assembly process associated with these two 
subunits is also impaired (Weraarpachai et al., 2009).  Mutations in LRPPRC are associated with 
French-Canadian type Leigh Syndrome (Lee et al., 2001; Mootha et al., 2003). Fibroblasts derived 
from these patients display reduced COX activity and assembled enzyme which is due to a decreased 
expression of COX mitochondrial transcripts, as well as those of some of Complex I (Sasarman et al., 
2010). This is most likely due to its role as a mRNA chaperone in mitochondria (Siira et al., 2017).     
 
4 – Modular Assembly 
In addition to the studies in budding yeast, investigations into COX assembly complexes 
were carried out in assembly factor and structural subunit deficient human cell lines that revealed a 
number of complexes not previously detected in wild-type cells.  These complexes were ordered 
based on antibody detection and metabolic radiolabelling of mitochondrial polypeptides into each 
complex.  This investigation identified COXIV (homolog to yeast COX5) as one of the first structural 
subunits to associate with COXI (Nijtmans et al., 1998), in agreement with yeast studies.  These 
subunits retain alternative isoforms that are regulated by oxygen concentration, perhaps indicating 
this is one of the first steps of COX assembly in eukaryotes where alternative subunits can be 
incorporated. This study also proposed that haem was incorporated into COXI early in the assembly 
process, followed by associations with the majority of other structural subunits.  However, the 
resolution of each structural subunit association was not accomplished in this work but paved the 
way for the study of the step-by-step assembly pathway. A patient suffering from Leigh Syndrome-
like symptoms was found to harbour a mutation in COX8A, a ubiquitously expressed isoform of 
COX8. This resulted in decreased COX activity in muscle biopsies and decreased expression of 
assembled COX without any evidence of accumulation of sub-assemblies (Hallmann et al., 2016). The 
other human isoform of COX8, COX8C, has a more restricted tissue distribution than COX8A, may be 
able to fulfil the role of COX8A when absent (Figure 4).   
Cells derived from Leber’s optic atrophy cells lacking SURF1 characterised using 2D gel 
electrophoresis identified four distinct COXI containing complexes similar to those identified in wild-
type cells.  Despite the absence of SURF1 protein, there was still some fully assembled COX present 
in these mutants (Tiranti et al., 1999).  This is consistent with yeast, where the absence of SHY1 does 
not completely inhibit COX assembly. This indicates the function of SURF1/SHY1 can be by-passed, 
either by the natural kinetics of assembly or by another protein.  Gene deletion approaches in 
cultured human cells have revealed the composition of some of these complexes. These complexes 
include an early CMC1-COA3-COX14 complex that assembles with newly synthesised COXI. A 
subsequent complex, known as MITRAC, contains COA3 (MITRAC12), COA1 (MITRAC15), COX1, 
COX4, COX5, COX6 with SURF1 and TIM21, a component of the IMM translocation machinery 
(Dennerlein et al., 2015; Mick et al., 2012).  Deletion of CMC1 results in a decreased expression of 
functional COX, but synthesis is not inhibited, like in budding yeast, indicating an alternative 
mechanism of regulation in human cells (Bourens and Barrientos, 2017).  RNA interference of 
MITRAC12 results in the complete loss of the MITRAC complex, reduced COXI synthesis and reduced 
COX activity (Mick et al., 2012).   
Several assembly factors have been identified as causative of disease for several groups of 
patients. This is the case for COA7, COA8, COX20, SCO1, SCO2, COA6 where deficiency of function or 
expression leads to decreased COX activity due to a decrease in the expression of fully assembled 
COX (Bourens et al., 2014; Leary et al., 2004; Martinez Lyons et al., 2016; Melchionda et al., 2014; 
Signes et al., 2018).  Using RNA interference, an assembly pathway in humans was proposed where 
COX1 assembles with COX4 and COX5a initially (sub-assembly S2), which then recruits mature COX2. 
The remaining structural subunits then associate including COX3 (sub-assembly S4* and S4).  
However, the order where subunits associated is not clear (Fornuskova et al., 2010).  Deficiency in 
COX20 results in an accumulation of S2 prior to the association of COX2 and other structural 
subunits. This accumulation supports the role of COX20 in the maturation of COX2, most likely 
through the copper centre formation (Szklarczyk et al., 2013).  Disease causing mutations associated 
with SCO2 deficiency also display an accumulation of sub-assemblies. SCO2 mutations result in 
decreased COX2 synthesis and distinct sub-assemblies (Leary et al., 2009). These sub-assemblies are 
different from the sub-assemblies associated with SURF1 deficiency – pointing to the roles these two 
assembly factors have for different catalytic core subunits (Stiburek et al., 2009). SCO1 is also 
required for COX2 maturation and mutations found in patients results in similar sub-assemblies as 
SCO2 mutations, indicating they are in the same pathway. Mutations in COA6 also reveal sub-
assemblies containing COXI and COXIV.  COA6 is a copper binding chaperone required for the 
biogenesis of COX2 (Ghosh et al., 2016, 2014; Pacheu-Grau et al., 2015; Stroud et al., 2015).  
Similarly, to budding yeast studies the assembly process of COXII and COXIII is less well understood. 
This is again likely to be due to the lower number of assembly factors required for COXII and COXIII 
assembly.  Assembly intermediates containing COXII and COXIII have not been described.  
 
The Assembly process of F1-FO ATP synthase.  
 
1 - Structure 
The mitochondrial proton-translocating  ATP synthase , the F1-FO complex, or complex V, 
utilizes a  proton motive force  to produce ATP from ADP and inorganic phosphate.  The complex 
consists of the membrane-embedded FO sector, responsible for the proton translocating activity, and 
the F1 sector, which catalyses the ATP synthesis. FO and F1 sectors are connected by the F1 central 
stalk and the peripheral stalk (Boyer, 1997).   Human complex V is an assembly of 29 subunits, the F1 
sector consists of a catalytic globular hexamer and the central stalk. The globular part is arranged in 
dimers of α (Atp1p) and β (Atp2p) subunits: α3β3.  Each dimer α/β possesses a nucleotide binding 
pocket. Of the six adenine nucleotide binding sites, three catalytic are located in the β subunits, and 
alternate position with the three non catalytic in the α (Ackerman and Tzagoloff, 2005). The core of 
the spherical hexamer is occupied by the γ (Atp3p) subunit, which protrudes from the central part 
where interacts with δ (Atp16p) and ε (Atp15p) subunits to form the central stalk (Rak et al., 2009).   
Differently of F1, FO protein composition of is not fairly constant across evolution.  The core 
subunits of FO found in both mitochondria and bacteria, are subunits a (Atp6p), b (Atp4p), and c 
(Atp9p).  In eukaryotes the FO sector embedded in the inner membrane contains the Atp9p/c ring 
with eight identical subunits in human or ten in yeast. Atp6p/a, which is associated to the Atp9p/c 
ring and forms the proton conduction pathway contains five transmembrane α-helices and an 
amphipathic α-helix that lies along the matrix surface (Guo et al., 2017). Atp4p/b has two N-terminal 
transmembrane α-helices, which form a domain with subunits e (Atp21p) and g (Atp20p); the 
soluble C-terminal portion of Atp4p/b enters the mitochondrial matrix as part of the peripheral stalk 
(Guo et al., 2017). Subunit f (Atp17p) consists of a soluble N-terminal sequence of ~50 residues that 
binds to the base of the peripheral stalk, followed by a single transmembrane α-helix. The subunit 8 
(Atp8p) N-terminus is intimately associated with Atp6p/a subunit and the C-terminal contributes to 
the base of the peripheral stalk (Guo et al., 2017; Srivastava et al., 2018). Subunit i/j (Atp18p in yeast 
or 6.8PL in human) is important for the stability of the  F1-FO ATP synthase dimer. 
The protonation and deprotonation events at the interface between Atp6p/a and Atp9p/c 
ring couple the translocation of protons to the rotation of the Atp9p/c-ring (Stock et al., 2000; 
Symersky et al., 2012). The C-terminal of the Atp9p/c protein contains negatively charged Glutamate 
residues exposed on the outside of the ring, which are neutralized by protons from the IMS. The 
protonation pathway during ATP synthesis is a path formed by subunits Atp6p/a, Atp4p/b, and 
Atp17p/f with the final course formed by helices 5 and 6 of Atp6p/a (Srivastava et al., 2018). As the 
protons passed by the channel and neutralize these residues, they change their conformation to 
move to a more hydrophobic environment, making the ring movement of the rotor, which induces 
conformational changes to the central stalk Atp3p (γ) subunit. Therefore, Atp3/γ transmits these 
rotational movements to the F1 catalytically head altering the nucleotide binding pockets 
conformation that leads to ATP production, while the peripheral stalk keeps the catalytic head static 
for the energy transducing process preventing from rotating along with the central rotor (Ackerman 
and Tzagoloff, 2005). Based on high resolution structural information, the peripheral stalk is 
composed of subunits OSCP (Atp5p),  b (Atp4p), d (Atp7p), h (Atp14p or F6 in human), f (Atp17p), i/j 
(Atp18p/6.8 PL) and Atp8p. Subunits Atp5p, Atp4p, Atp7p, Atp14p/F6, and Atp17p  primarily serve as 
structural components of the stator (Guo et al., 2017) while, subunits Atp4p, Atp7p, Atp17p, 
Atp18p/6.8 PL and Atp8p are also part of the complex purified as Fo, and may have a role in proton 
movement in addition to a structural role in forming the stator (Srivastava et al., 2018).  
 Non-essential structural components of F1-FO ATP synthase include subunits e (Atp21p), g 
(Atp20p) and k (Atp19p in yeast or DAPIT in human), which are associated with the dimeric form of 
the enzyme (Arnold et al., 1998b).  Subunits e, f, g , DAPIT and 6.8PL are also  known as 
supernumerary with no direct role in the synthesis of ATP. They are all localized in the region of 
interaction between monomers in the dimeric complex. Indeed, individual deletion of human 
subunits e, f, g, and 6.8PL disrupts dimerization, while deletion of DAPIT influences oligomerization 
of dimers (He et al., 2018). 
The fully assembled F1FO-ATP synthase dimerizes via Atp4p transmembrane helixes by the 
incorporation of Atp20p and Atp21p and by the assistance of Atp18p and Atp19p/DAPIT  (Davies et 
al., 2014, 2012; Wagner et al., 2010). The dimer is held together by subunits Atp6p, Atp18p/6.8PL, 
Atp19p/DAPIT, and Atp21p/e  (Guo et al., 2017; He et al., 2018). The formation of F1-FO  ATP synthase 
dimers plays a major role in determining the structure of mitochondrial morphology and 
consequently the cristae formation and local increase in membrane potential (Paumard et al., 2002). 
The curved structure of the domain formed by Atp20p, Atp21p and the N-terminal of Atp4p, with 
further support from Atp19p/DAPIT explain how these subunits bend the lipid bilayer (Guo et al., 
2017).  Indeed, ATP synthase dimers are self-assembled into rows, which are able to bend the 
membrane (Blum et al., 2019). It was recently demonstrated that assembly of the F1-FO ATP synthase 
complex occurs in the cristae bends favouring the complex V intermediate accumulation and 
consequently a continuous of cristae formation (Stoldt et al., 2018).  
Regulatory auxiliary proteins are also associated to F1-FO ATP synthase. Inhibitory proteins 
Inh1p, Sft1pand Stf2p modulates the hydrolytic activity of the complex in yeast. In human 
mitochondria IF1 inhibits the complex by binding to one of the catalytic α-β interfaces  (Ackerman 
and Tzagoloff, 2005; Hashimoto et al., 1990; Robinson et al., 2013). Dephosphorylated IF1 inhibits 
the synthase and hydrolytic activity of the ATP synthase (García-Bermúdez et al., 2015) the protein 
has a short half-life, its expression is tissue dependent and controlled at posttranscriptional levels by 
S39 phosphorylation (García-Aguilar and Cuezva, 2018). 
 
2 - Mitochondrial Gene expression  
The monomeric form of F1-FO  ATP synthase contains 18 subunits in humans, including the 
regulatory IF1 (Srivastava et al., 2018), whose expression relies on information from two 
compartmentally separated genomes. An extraordinary situation, which raise the question of how 
two compartmentally separated genome communicate to express balanced output of gene products 
destined to be subunits of the same enzyme. In the yeast S. cerevisiae three subunits: Atp6p, Atp8p 
and Atp9p are mitochondrially encoded while in animals and in filamentous fungi only Atp6p and 
Atp8p remained encoded by the organelle. Curiously, Neurospora crassa and Aspergillus nidulans 
have both the nuclear and the mitochondrial version of Atp9p (Rak et al., 2009). At any rate, 
synthesis of Atp9p and Atp6p must be strictly regulated to prevent accumulation of unassembled 
proton channels that may lead to dissipation of the membrane potential.  
Biogenesis of  F1-FO  ATP synthase  is assisted by some dozen nuclear gene products that 
intercede at all stages of the assembly pathway (Ackerman and Tzagoloff, 2005). Most of these 
factors in yeast target the mitochondrial ATP6, ATP8, ATP9 mRNAs and their products since 
regulatory mechanisms can occur in the different steps of the mitochondrial gene expression, for 
instance, every single mRNA needs to be activated by a specific protein in order to be translate in 
the mitoribosomes (Costanzo and Fox, 1990). ATP8 and ATP6 are transcribed on a polycistronic RNA 
together with COX1, while ATP9 is co-transcribed with tRNAser and VAR1 (Rak et al., 2009). ATP9 
mRNA requires Aep1p/Nca1p, Aep2p/Atp13p and Atp25p (Ackerman et al., 1991; Zeng et al., 2008) 
for its stabilization. Aep1p/Nca1p and Aep2p/Atp13p are also considered potential translational 
activators of the ATP9 mRNA  (Godard et al., 2011).  In human, ATP8 and ATP6 are also transcribed 
in a bi-cistronic mRNA unit with a 46-nucleotide overlap (Fearnley and Walker, 1986). Differently of 
other mitochondrial mRNAs, addition of the poly-A tail to ATP8/6 mRNA decreases its stability, while 
its removal depends on the PDE12 factor (Rorbach et al., 2011).  According to the MITOMAP 
database 48 different mutations in these two genes have already been identified. As typically found 
in mitochondrial genetic disorders mutations that cluster in specific regions of ATP6 or ATP8 also 
give rise to a wide variety of clinical symptoms (Dautant et al., 2018).  
In contrast to the human ATP6-ATP8 transcript, various proteins have been described in 
yeast affecting ATP6-ATP8 expression.  Nca2p, Nca3p, Aep3p and Atp22p were previously shown to 
affect expression of Atp6 and Atp8p by either stabilizing (Camougrand et al., 1995; Ellis et al., 2004; 
Pélissier et al., 1995) or activating translation of the bicistronic ATP8-ATP6 mRNAs (Barros and 
Tzagoloff, 2017; Zeng et al., 2007a). Although together in the same mature mRNA ATP6 and ATP8 
have different translation activators; translation of ATP6 is strictly dependent on Atp22 (Zeng et al., 
2007a) and translation of ATP8 depends on Aep3p, which is also necessary for mRNA stabilization as 
mentioned above (Barros and Tzagoloff, 2017; Ellis et al., 2004).  
The Aep1p/Nca1p, Aep2p/Atp13p, Aep3p and Atp22p proteins required for ATP9 and 
ATP6/8  mRNA stabilization and translational activation contains (PPR) motifs (Herbert et al., 2013), 
which consists of  repeated in tandem in two antiparallel α-helices leading to a helix-turn helix 
domain, which form an RNA-binding groove (Manna, 2015).  
Translational control of the bicistronic ATP8/ATP6 mRNA by assembled F1 ATPase ensures a 
balanced output of the nuclear F1FO-ATPase complex and mitochondrial subunits (Rak and Tzagoloff, 
2009). In a very interesting mechanism, translation of ATP6 mRNA is repressed by Smt1p and 
maintains the ATP8/ATP6 mRNA in a translation mute form when F1 is in limiting conditions (Rak et 
al., 2016), with fully assembled F1, Smt1p is displaced allowing the recognition of the mRNA by 
Atp22p, the Atp6p translational activator. Indeed, in the absence of Aep3p, the putative Atp8p 
translational activator, low expression of a nuclear version of ATP8 can complement the aep3 
mutant if smt1 is also mutated (Barros and Tzagoloff, 2017). 
To date it is still elusive the existence of mitochondrial translational activators in human 
mitochondria, however many unstudied factors have been identified in mitochondrial RNA granules, 
which are centers for posttranscriptional RNA processing (Antonicka and Shoubridge, 2015). 
Mitochondrial translation has been demonstrated to occur at different sites of the IMM: the 
inner boundary membrane (IBM), which parallels the outer membrane, and the cristae membrane 
(CM), which projects into the mitochondrial matrix (Stoldt et al., 2018). Proteins involved in the 
biogenesis of of  F1-FO  ATP synthase such as Atp22p, Atp25p (C-terminus) and Atp10p are particularly 
enriched in the CM, which as mentioned earlier favoured the formation of the cristae structures in 
the mitochondrial inner membrane (Stoldt et al., 2018). 
 
3 – Protein Assistance in the Assembly process  
 
3.1 - FO assembly 
Formation of FO is a protein assisted process, dependent of Atp10p, Atp23p, Ina17p and 
Ina22p proteins. Following synthesis on mitoribosomes Atp6p is bound to Atp10p, whose association 
protects Atp6p from proteolysis and assists the assembly of Atp6p into FO (Ackerman and Tzagoloff, 
1990a; Tzagoloff et al., 2004). In fact, Atp6p is subjected to proteolysis processes in mitochondria 
with reduced levels of the stator component Atp14p (Goyon et al., 2008). Interestingly the atp10 
null mutant can be suppressed by mutations in the Atp6p C-terminus that increase the protein 
stability  (Paul et al., 2000). In fact, it was demonstrated that in the process of FO assembly Atp10p 
associates with the Atp6p/Atp8p intermediate (Naumenko et al., 2017; Rak et al., 2011) in a complex 
that also contains components of the peripheral stalk and Atp23p (Naumenko et al., 2017). Atp10p is 
a 30 kDa IMM protein; homologues of Atp10p can be found in many eukaryotes groups but not in 
metazoa and green algae (Pícková et al., 2005). Atp23p is a metalloprotease with the catalytic center 
formed by the HEXXH motif that processes the 10 amino acid N-terminal signal sequence of Atp6p 
(Osman et al., 2007; Zeng et al., 2007c).  ATP23 is amplified in human glioblastomas, and several 
transcript variants encoding different isoforms have been found for this gene.  The construction of 
an atp23 mutant with a point mutation in the catalytic center revealed that the removal of the 
Atp6p N-terminus is not essential for biogenesis of the F1-FO  ATP synthase (Zeng et al., 2007b).  
However, the physical participation of Atp23p in FO assembly process  can be considered the 
essential role of Atp23p for F1FO-ATPase assembly. A genetic association between ATP23 and ATP10 
was also observed, ATP23 overexpression rescues the respiratory growth of atp10 mutants (Zeng et 
al., 2007c), suggesting that Atp23p excess can overcome the lack of Atp10p.  Finally, the importance 
of Atp6p N-terminus was assessed in atp6 variants lacking the N-terminus, these mutants although 
respiratory competent presented decreased efficiency in the assembly of the F1-FO  ATP synthase 
(Zeng et al., 2007c).  
 It was demonstrated that Atp23p interacts with Atp10p in multiple protein complexes that 
also contains Atp6p/Atp8p intermediates in ina22 null mutants (Naumenko et al., 2017). According 
to a steady state study performed in yeast cells there is no free pool of Atp23p in mitochondria, and 
the protein seems to exist only associated to F1FO-ATPase assembly intermediates (Naumenko et al., 
2017). Ina22p together with Ina17p constitute the INA complex (INAC). Both proteins interact with 
each other in coiled-coil domains, Ina22p becomes unstable in ina17 mutants (Lytovchenko et al., 
2014).   Ina22p is integrated in the IMM with a single transmembrane anchor, interacting with 
subunits of the peripheral stalk specially Atp4p, which has a central role in the peripheral stalk 
structure.  Mitochondria lacking Ina22p show defects in the assembly of the stator proteins Atp4p, 
Atp5p, and Atp14p resulting in the accumulation of free F1 module in the matrix (Lytovchenko et al., 
2014). Importantly, INAC is not essential for F1FO-ATPase biogenesis, as the mature complex is still 
present in mutant mitochondria (Lytovchenko et al., 2014).  ATPase mitochondrially encoded genes 
have their expression altered in ina22 mutants, i.e., the rate of Atp6p and Atp8p translation is 
augmented (Naumenko et al., 2017), probably due to an augment of free F1 , which as mentioned 
before control the translation of the bicistronic ATP8/ATP6 mRNA (Rak and Tzagoloff, 2009). 
Oppositely, the level of newly synthesized Atp9 and consequently ring formation is reduced in these 
mutants (Naumenko et al., 2017).   
 
3.2 - Atp9p/c ring formation 
The human genome contains three genes ATP5G1, ATP5G2, and ATP5G3 encoding for the c 
subunit, they are identical with slight differences in the amino-terminus mitochondrial targeting 
sequence. The disruption of the three genes altogether leads to formation of an incomplete F1FO-
ATPase not only devoid of the c ring but also without subunits a, 8, 6.8PL and DAPIT (He et al., 
2017b).   
Newly synthesized Atp9p subunits are not immediately incorporated into the Atp9p ring.  
Even though, the oligomerization of Atp9p has been assumed to occur spontaneously, different 
proteins have been described to be involved in this process.  In E. coli c-ring oligomerization depends 
on the uncI gene product (Ozaki et al., 2008), and in yeast this process depends on the two-domain 
protein Atp25p (Zeng et al., 2008). ATP25 codes for a protein that consists of two isolated and 
independent domains: an N-terminal domain related to the Rsf (ribosome silencing factor) of 
bacteria and the C-terminal necessary to stabilize the ATP9 mRNA (Woellhaf et al., 2016; Zeng et al., 
2008).  The Atp25p N-terminus was shown to be associated to the mitoribosomes (Woellhaf et al., 
2016) as well as a role in the c-ring oligomerization has been proposed (Rak et al., 2011; Zeng et al., 
2008). In fact, the oligomerization of Atp9p is considered a slow process, in comparison to 
Atp6p/Atp8p association (Zeng et al., 2008), but some factors have also been described as 
facilitators of this process, such as Oxa1p the mitochondrial translocase protein (Jia et al., 2007). The 
insertion of Atp9p into the IMM does not depend on the translocase activity of Oxa1p, but the 
formation of the Atp9p ring is facilitated by Oxa1p chaperone ability  (Jia et al., 2007). Also 
interestingly, the Atp9p ring formation is specifically reduced in the cox6 mutant, a cytochrome c 
oxidase deficient mutant (Su et al., 2014b). Indeed, newly synthesized Atp9p can be pulled down 
with a tagged version of Cox6 (McStay et al., 2013a). Therefore, the presence of unassembled Atp9p 
in large molecular complexes can be part of a regulatory process necessary for the proper assembly 
of the Atp9p ring into the mature F1FO-ATPase. 
 
3.3 - The F1 catalytic head 
The F1 sector assembles independently of the FO subunits (Schatz, 1968; Tzagoloff, 1969), its 
biogenesis requires the general chaperones Hsp60, Hsp70, Hsp90 and at least three specific factors 
Atp11p/ATPAF1, Atp12p/ATPAF2 and Fmc1p (Ackerman and Tzagoloff, 2005; Wang et al., 2001). 
 Therefore, the formation of the α3β3 hexamer sub-structure is a protein-assisted process. 
Atp11p and Atp12p interact with the β and α subunits, respectively, and function as molecular 
chaperones that stabilize unassembled α and β subunits by shielding their hydrophobic surfaces 
(Ackerman and Tzagoloff, 2005, 1990b). Atp11p binds to the β subunit at the nucleotide binding 
domains (Wang and Ackerman, 2000), while Atp12p binds to the α subunit at the pre-interface 
surface that will form the non-catalytic site with a neighbouring β subunit (Wang et al., 2000). 
Therefore, loss of Atp11p and Atp12p leads to aggregation of subunits α and b, and consequently 
impairs the assembly of the F1 sector (Wang et al., 2000). Indeed, efficient production of 
recombinant bovine mitochondrial F1 in Escherichia coli depends on the expression of human Atp11p 
(AF1) and Atp12p (AF2) (Suzuki et al., 2016).  
It has been proposed that the association of the central stalk to the Atp11p-Atp12p- α3β3 
hexamer provoke the release of Atp11p and Atp12p and the formation of the F1 sector. Structural 
analyses reveal that the C-terminal region of Atp12p and the coiled coil tail of the γ-subunit are 
structurally similar, prompting the hypothesis that the binding of Atp3p to the Atp12p-α complex 
initiates the release of Atp12p and Atp11p chaperones from α and β and their further assembly into 
the mature sector (Ludlam et al., 2009). Fmc1p is not present in metazoa (Pícková et al., 2005), it is 
considered an Atp12p specific chaperone and it is required for F1 assembly under conditions of heat 
stress (Lefebvre-Legendre et al., 2001).  Interestingly, fmc1 mutants can be suppressed by ATP12 
excess that indicates a function of Fmc1p in Atp12p folding or stabilization. A direct role of Fmc1p in 
Atp12p was also suggested in a study using the pathogenic human Atp12p W94R mutation in yeast, 
this atp12 mutant became insoluble in yeast only in the absence of Fmc1p (Meulemans et al., 2010).  
Proteins homologous to Atp12p are widely present in eukaryotes; the same is true for Atp11p, 
except for some groups of nematodes, on the other hand, Fmc1p is restricted to the fungi kingdom 
(Pícková et al., 2005). 
 
4 - Modular Assembly 
In the process for the assembly of the mature F1FO-ATPase complex, different modules have 
been identified, particularly in the formation of the FO sector and the peripheral stalk (Figure 5). As 
mentioned earlier the soluble F1 sector was shown to assemble as an independent unit. Two distinct 
modules assemble the FO sector: the Atp9p ring (c-ring) and the Atp6p/Atp8p (a/8) complex 
(Naumenko et al., 2017; Rak et al., 2011). The modular assembly F1FO-ATPase depends on the INA 
complex, which interacts physically with two distinct subassemblies modules: the Atp9p ring and 
Atp6p/Atp8p intermediate (Naumenko et al., 2017). Human ρ0 cells devoid of mitochondrial DNA, 
which cannot make subunits Atp6p/a and Atp8p are still able to synthesize the c-ring and F1-
peripheral stalk module (He et al., 2017b).  
In contrast to the Atp9p ring formation, the Atp6p/Atp8p stator subcomplex intermediate is 
a very fast process that include the association of the peripheral stalk subunits Atp4p, Atp7p, 
Atp14p, OSCP/Atp5p and the chaperones Atp10p and Atp23p (Naumenko et al., 2017; Rak et al., 
2011). In fact, the observed association between the Atp6p/Atp8p intermediate with OSCP protein 
could only be detected under low salt conditions (Naumenko et al., 2017). Based on Atp10p pull 
down assays performed from cells devoid of ina22, it has been proposed a mechanism in which the 
INAC mediate the assembly of the mature F1FO-ATPase complex, through the association of 
Atp6p/Atp8p with the peripheral stalk and the F1 sector. Only after the formation of this 
intermediate the Atp9p ring is added, ensuring the coupling of proton movement to ATP production 
(Naumenko et al., 2017). However, in atp6 or atp8 null mutants F1 pull down assays revealed the 
association of F1 with the Atp9p ring independently of the presence of the Atp6p/Atp8p 
intermediate (Rak et al., 2011). The formation of an F1-Atp9p ring intermediate was also observed in 
human cells with ATP6 expression suppressed (Fujikawa et al., 2015). In another study it was shown 
that in mitochondrial translocase mutant (oxa1) the Atp9p ring is accumulated associated with F1 but 
not with Atp6p, therefore, it was proposed that Oxa1p makes the Atp9p ring ready for Atp6p/Atp8p 
intermediate assembly (Jia et al., 2007). 
More recently, the use of gene editing techniques has allowed the removal of specific 
subunits of the F1FO-ATPase complex and therefore allowing the study of assembly intermediates 
and the formation of vestigial F1FO-ATPase in human cells (He et al., 2017a, 2017b).  Indeed, the 
study of vestigial F1FO-ATPase complex in human cell lines devoid of supernumerary components or 
peripheral stalk subunits also indicate a different order of events in the human F1FO-ATPase 
assembly in comparison to yeast (He et al., 2018).  In this study, cells lacking subunits e, f, g, DAPIT, 
and 6.8PL can assemble the remaining subunits into an incomplete ATP synthase complex with 
severe outcomes on cell respiration, except for DAPIT removal, which retained almost normal levels 
of the wild type respiratory capacity.  Moreover, with this strategy the authors found that an F1/c 
ring intermediate is formed prior to the addition of the peripheral stalk components and the last 
step for the formation of the F1FO-ATPase is the association with the Atp6/Atp8 intermediate (He et 
al., 2018). In another study, the knock down of Atp7, a peripheral stator subunit, human cells 
accumulated two subcomplexes, one containing a central rotor shaft plus catalytic subunits (F1- Atp9 
ring) and the other containing Atp4, Atp20 and Atp21 stator stalk components (Fujikawa et al., 
2015). It is worthwhile to note that the yeast assembly factors Atp10p, Ina22p and Ina17p are not 
present in human cells, which can account for these differences in the order of events for the 
assembly of the mature F1FO-ATPase complex. 
 
Conclusion 
The complexity of the OXPHOS system can be immediately appreciated by the number of complexes, 
the number of subunits and co-factors each complex is composed of, the functions of each complex, 
the assembly factors required for each complex, the location of the complexes and the dual genetic 
origin of the complexes. With so many requirements there is a seemingly high likelihood of error 
that would be detrimental to cellular function and organismal health. Owing to the fundamental use 
of electrochemical gradients across membranes in all forms of cellular life the evolutionary pressures 
on maintaining functional complexes must be powerful. As life became more complex and adapted 
to different environments and developmental stages the control of assembly and function evolved 
to be more intricate. The conservation of function from bacteria to single celled and multicellular 
eukaryotes has enabled a deep knowledge of OXPHOS complex assembly that is being used to 
understand the process further but to also understand the origins of eukaryotic life as well 
treatments of human disease.   
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